FASN and neoplasm: Figure 5 shows representative histological sections of excised tumours at Day 4 after treatment with vehicle or combination of cisplatin and orlistat (ORL/CP D2 cohort), stained with H&E (Fig. 5a), cleaved caspase‐3 antibody (Fig. 5b) and FASN antibody (Fig. 5c).